ADmit Therapeutics
Barcelona, ES · 3 known investors
Find your way into ADmit Therapeutics
Admit Therapeutics is a diagnostics and pharmaceutical company focused on neurological diseases, particularly Alzheimer's and dementia, leveraging AI/ML for biomarker analysis and clinical laboratory services. The company serves medical institutions and healthcare providers developing and deploying advanced diagnostic solutions.
Founders & leadership
MB
Marta BarrachinaCEO, Co-Founder
RR
Ramón ReñéCo-Founder
JG
Jordi GascónCo-Founder
Investors · 3
Frequently asked questions
- What does ADmit Therapeutics do?
- Admit Therapeutics is a diagnostics and pharmaceutical company focused on neurological diseases, particularly Alzheimer's and dementia, leveraging AI/ML for biomarker analysis and clinical laboratory services. The company serves medical institutions and healthcare providers developing and deploying advanced diagnostic solutions.
- Who founded ADmit Therapeutics?
- ADmit Therapeutics was founded by Marta Barrachina, Ramón Reñé, Jordi Gascón.
- Who are ADmit Therapeutics's investors?
- ADmit Therapeutics's investors include BStartup, Ship2B, WA4STEAM.
- Where is ADmit Therapeutics headquartered?
- ADmit Therapeutics is headquartered in Barcelona, ES.